<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A large body of evidence supports a role of <z:mp ids='MP_0003674'>oxidative stress</z:mp> in <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (AD) and in cerebrovascular disease </plain></SENT>
<SENT sid="1" pm="."><plain>A vascular component might be critical in the pathophysiology of AD, but there is a substantial lack of data regarding the simultaneous behavior of peripheral <z:chebi fb="11" ids="22586">antioxidants</z:chebi> and biomarkers of <z:mp ids='MP_0003674'>oxidative stress</z:mp> in AD and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) </plain></SENT>
<SENT sid="2" pm="."><plain>Sixty-three AD patients, 23 VaD patients and 55 controls were included in the study </plain></SENT>
<SENT sid="3" pm="."><plain>We measured plasma levels of water-soluble (<z:chebi fb="122" ids="21241">vitamin C</z:chebi> and <z:chebi fb="3" ids="27226">uric acid</z:chebi>) and lipophilic (vitamin E, vitamin A, <z:chebi fb="2" ids="23044">carotenoids</z:chebi> including <z:chebi fb="0" ids="28838">lutein</z:chebi>, <z:chebi fb="0" ids="27547">zeaxanthin</z:chebi>, <z:chebi fb="0" ids="10362">beta-cryptoxanthin</z:chebi>, <z:chebi fb="0" ids="15948">lycopene</z:chebi>, alpha- and <z:chebi fb="9" ids="17579">beta-carotene</z:chebi>) <z:chebi fb="11" ids="22586">antioxidant</z:chebi> micronutrients as well as levels of biomarkers of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation [malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>)] and of protein oxidation [immunoglobulin G (IgG) levels of protein <z:chebi fb="1" ids="23019">carbonyls</z:chebi> and <z:chebi fb="0" ids="50607">dityrosine</z:chebi>] in patients and controls </plain></SENT>
<SENT sid="4" pm="."><plain>With the exception of <z:chebi fb="9" ids="17579">beta-carotene</z:chebi>, <z:hpo ids='HP_0000001'>all</z:hpo> <z:chebi fb="11" ids="22586">antioxidants</z:chebi> were lower in <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> patients as compared to controls </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, AD patients showed a significantly higher IgG <z:chebi fb="0" ids="50607">dityrosine</z:chebi> content as compared to controls </plain></SENT>
<SENT sid="6" pm="."><plain>AD and VaD patients showed similar plasma levels of plasma <z:chebi fb="11" ids="22586">antioxidants</z:chebi> and <z:chebi fb="14" ids="32506">MDA</z:chebi> as well as a similar IgG content of protein <z:chebi fb="1" ids="23019">carbonyls</z:chebi> and <z:chebi fb="0" ids="50607">dityrosine</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that, independent of its nature-vascular or degenerative-<z:hpo ids='HP_0000726'>dementia</z:hpo> is associated with the <z:mpath ids='MPATH_63'>depletion</z:mpath> of a large spectrum of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> micronutrients and with increased protein oxidative modification </plain></SENT>
<SENT sid="8" pm="."><plain>This might be relevant to the pathophysiology of dementing disorders, particularly in light of the recently suggested importance of the vascular component in AD development </plain></SENT>
</text></document>